Posted On: 12/03/2014 1:06:13 AM
Post# of 30066
In goes:
Lympro @ $120K, Eltoprazine @ $600K, MANF @ $59K, & ESS-W @ $11.2M
Out comes:
Lympro ready to go, valued at $TBD
MANF Blockbuster(s)
Nov. 25, 2014 - "We firmly believe MANF has blockbuster potential in ophthalmology, neurology, cardiology and metabolic disorders, including diabetes"
Eltoprazine Blockbuster
Dec. 2, 2014 - "We expect to have two phase three ready programs by 2016 so this is realy something we are extremely excited about. The sales here for PD LID are expected for a drug that actually works in synication to be over a billion dollars. This really does have blockbuster potential."
Lympro @ $120K, Eltoprazine @ $600K, MANF @ $59K, & ESS-W @ $11.2M
Out comes:
Lympro ready to go, valued at $TBD
MANF Blockbuster(s)
Nov. 25, 2014 - "We firmly believe MANF has blockbuster potential in ophthalmology, neurology, cardiology and metabolic disorders, including diabetes"
Eltoprazine Blockbuster
Dec. 2, 2014 - "We expect to have two phase three ready programs by 2016 so this is realy something we are extremely excited about. The sales here for PD LID are expected for a drug that actually works in synication to be over a billion dollars. This really does have blockbuster potential."
(0)
(0)
